Ninety One UK Ltd decreased its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 3.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 212,368 shares of the financial services provider's stock after selling 7,904 shares during the period. Ninety One UK Ltd owned 0.06% of CME Group worth $44,725,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in CME. Norges Bank bought a new stake in shares of CME Group in the 4th quarter worth approximately $610,482,000. Morgan Stanley increased its position in CME Group by 31.5% in the 3rd quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider's stock valued at $972,863,000 after acquiring an additional 1,163,103 shares during the period. PineStone Asset Management Inc. increased its position in CME Group by 261.4% in the 3rd quarter. PineStone Asset Management Inc. now owns 1,280,194 shares of the financial services provider's stock valued at $256,320,000 after acquiring an additional 925,939 shares during the period. Barclays PLC increased its position in CME Group by 90.0% in the 2nd quarter. Barclays PLC now owns 1,218,481 shares of the financial services provider's stock valued at $225,771,000 after acquiring an additional 577,293 shares during the period. Finally, 1832 Asset Management L.P. increased its position in CME Group by 992.8% in the 1st quarter. 1832 Asset Management L.P. now owns 623,999 shares of the financial services provider's stock valued at $119,508,000 after acquiring an additional 566,899 shares during the period. Institutional investors own 87.75% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts recently commented on CME shares. Rosenblatt Securities restated a "sell" rating and issued a $180.00 target price on shares of CME Group in a research report on Thursday, January 4th. Argus raised their target price on CME Group from $225.00 to $245.00 and gave the company a "buy" rating in a research report on Wednesday, March 6th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating and set a $210.00 price target (down from $235.00) on shares of CME Group in a research report on Friday, April 5th. Barclays lifted their price target on CME Group from $225.00 to $226.00 and gave the company an "equal weight" rating in a research report on Monday, April 8th. Finally, Morgan Stanley lifted their price target on CME Group from $222.00 to $225.00 and gave the company an "equal weight" rating in a research report on Tuesday, April 9th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, CME Group currently has an average rating of "Hold" and an average price target of $215.70.
Check Out Our Latest Stock Analysis on CME
CME Group Price Performance
Shares of NASDAQ CME traded up $3.39 during mid-day trading on Friday, reaching $213.04. The company had a trading volume of 2,563,919 shares, compared to its average volume of 1,776,882. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $76.69 billion, a PE ratio of 24.02, a P/E/G ratio of 5.92 and a beta of 0.49. The company has a 50-day moving average price of $214.42 and a two-hundred day moving average price of $211.70. CME Group Inc. has a 1-year low of $175.73 and a 1-year high of $223.80.
CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.27 by $0.10. The business had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.43 billion. CME Group had a return on equity of 12.32% and a net margin of 57.83%. The company's quarterly revenue was up 19.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.92 EPS. On average, equities analysts anticipate that CME Group Inc. will post 9.56 earnings per share for the current year.
CME Group Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were issued a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.16%. This is a boost from CME Group's previous quarterly dividend of $1.10. The ex-dividend date of this dividend was Thursday, March 7th. CME Group's payout ratio is presently 51.86%.
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
